The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 305.50
Ask: 306.50
Change: 3.50 (1.16%)
Spread: 1.00 (0.327%)
Open: 300.00
High: 306.50
Low: 300.00
Prev. Close: 302.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

29 Jun 2023 17:06

RNS Number : 4461E
Morgan Advanced Materials PLC
29 June 2023
 

Morgan Advanced Materials plc (the "Company")

 

RESULTS OF ANNUAL GENERAL MEETING

 

The Company confirms that all resolutions set out in the notice of its 2023 Annual General Meeting were duly passed by the requisite number of shareholders on a poll, at the meeting held on 29 June 2023. 

 

The poll results of each resolution are set out below. The number of the Company's Ordinary shares carrying the right to vote at the meeting was 285,369,988.Each share carried one vote.

 

Resolution

Votes For

(see note 1)

Votes Against

(see note 1)

Votes Withheld

(see note 2)

Total Votes Cast

(excl. withheld votes)

% of total issued share capital voted (excl. withheld votes)

Number of shares

% of total voted

Number of shares

% of total voted

1. To receive the audited accounts and the Auditor's and Directors' Reports for the year ended 31 December 2022

238,823,846

100.00%

4,475

0.00%

189,575

238,828,321

83.69

2. To approve the Directors' Remuneration Report

234,867,882

98.30%

4,064,024

1.70%

85,987

238,931,906

83.73

3. To approve the final dividend

238,997,000

100.00%

1,405

0.00%

19,491

238,998,405

83.75

4. To re-elect Jane Aikman as a Director

237,238,824

99.27%

1,755,660

0.73%

23,412

238,994,484

83.75

5. To elect Richard Armitage as a Director

238,195,449

99.67%

799,035

0.33%

23,412

238,994,484

83.75

6. To re-elect Helen Bunch as a Director

236,113,303

98.80%

2,871,181

1.20%

33,412

238,984,484

83.75

7. To elect Ian Marchant as a Director

238,812,844

99.92%

180,530

0.08%

24,522

238,993,374

83.75

8. To re-elect Laurence Mulliez as a Director

237,037,675

99.18%

1,956,809

0.82%

23,412

238,994,484

83.75

9. To re-elect Pete Raby as a Director

238,779,628

99.91%

214,856

0.09%

23,412

238,994,484

83.75

10. To re-elect Clement Woon as a Director

237,093,268

99.20%

1,901,216

0.80%

23,412

238,994,484

83.75

11. To re-appoint Deloitte LLP as Auditor of the Company

238,688,437

99.94%

148,775

0.06%

180,684

238,837,212

83.69

12. To authorise the Audit Committee of the Board of Directors to determine the Auditor's remuneration

238,977,572

99.99%

33,322

0.01%

7,002

239,010,894

83.75

13. To authorise the Company and its subsidiaries to make political donations and incur political expenditure

235,999,781

98.75%

2,999,299

1.25%

18,816

238,999,080

83.75

14. To authorise the Directors to allot shares

231,272,013

96.76%

7,737,059

3.24%

8,824

239,009,072

83.75

15.* To empower the Directors to generally disapply pre-emption rights up to a specified limit

238,333,803

99.72%

674,517

0.28%

9,576

239,008,320

83.75

16.* To empower the Directors to disapply pre-emption rights in connection with acquisitions or capital investments up to a specified limit

236,048,066

98.76%

2,966,199

1.24%

3,631

239,014,265

83.76

17.* To authorise the Company to purchase its own Ordinary shares up to the specified limit

237,993,450

99.58%

1,000,506

0.42%

23,940

238,993,956

83.75

18.* To enable the Company to convene a general meeting (other than AGMs) on at least 14 days' notice

233,447,438

97.67%

5,567,937

2.33%

2,521

239,015,375

83.76

 

 

In accordance with Listing Rule 9.6.2, copies of the resolutions passed by Morgan Advanced Materials plc shareholders concerning items other than ordinary business have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstorage

 

Board Changes

Further to the announcement on 18 January 2023, the Company confirms that Douglas Caster has retired as Chair and Non-executive Director and that Ian Marchant has taken over as Chair following the conclusion of the AGM today.

 

Notes:

 

1. Votes "for" and "against" are expressed as a percentage of votes received. Votes "for" include those at the Chairman's discretion.

2. Votes "withheld" are not votes in law and, therefore, have not been included in the calculation of the proportion of votes "for" or "against" a resolution.

* Indicates special resolution.

 

 

Enquiries: Win Chime, Company Secretary

 

Email: Company.Secretariat@morganplc.com

 

 

Legal Entity Identifier: I4K14LL95N2PHDL7EG85

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEIFMUEDSESM
Date   Source Headline
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.